Lupin 2024

Robert Long

Sanofi cleared to market OTC Xyzal allergy medicine

Sanofi cleared to market OTC Xyzal allergy medicine

BRIDGEWATER, N.J. — Sanofi is adding to its roster of prescription-to-OTC allergy medications with Xyzal Allergy 24HR. The Food and Drug Administration has approved Xyzal Allergy 24HR (levocetirizine dihydrochloride) as an over-the-counter treatment to alleviate symptoms of seasonal and year-round allergies, Sanofi said Wednesday. The product offers proven 24-hour relief from runny nose, sneezing, itchy

Centrum 7/6  banner